Across all domains of life, immune defenses foil invading viruses by making it impossible for the viruses to replicate. Most ...

Global Serological Testing Market OverviewThe global serological testing market is projected to grow at a compound annual growth rate (CAGR) of approximately 6–8% through 2027. Market expansion is ...

WHO noted that prequalified tests can now be prioritized in pooled procurement mechanisms, which help lower prices, stabilize ...

Roche’s cobas liat Bordetella test earns FDA clearance, delivering accurate whooping cough results in 15 minutes.

As folks travel to see loved ones for the holiday season, there’s one thing no one wants to pack — an infectious disease. But whether you have the sniffles or just want to take precautions around ...

As we get into another winter holiday season, COVID is still part of our lives. And although it's hard to predict exactly what this year's cold, flu and coronavirus season will look like, experts want ...

Switzerland-based Roche this week said it has received U.S. regulatory clearance for an Alzheimer’s blood test. This test is used in primary care offices for a patient’s initial assessment of ...

(Reuters) -Roche Diagnostics said on Monday the U.S. Food and Drug Administration cleared its and partner Eli Lilly's blood test as an aid in the initial assessment for Alzheimer's disease. This comes ...

Swiss-based Roche announced this month that it has received U.S. regulatory clearance for a less-complex vitamin D test in the United States, which the company said opens the door to more efficient ...

As summer comes to an end, COVID-19 cases are on the rise again in California. While respiratory viruses usually peak in the winter, the novel coronavirus can also surge in the warmer months.

Researchers at Arizona State University have developed a breakthrough diagnostic tool that could transform how quickly and reliably we detect illnesses like COVID-19, Ebola, AIDS or Lyme disease. The ...

Roche has obtained European approval for a blood test to help rule out Alzheimer’s disease, allowing patients to avoid additional exams for the condition after showing signs of cognitive decline. The ...